Canlyniadau Chwilio am Awdur

1

Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future gan Arghya Ray, Bengt Nordén

Cyhoeddwyd 2000

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma gan Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2020

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study gan Arghya Ray, Sandra W. Cowan‐Jacob, Paul W. Manley, Jürgen Mestan, James D. Griffin

Cyhoeddwyd 2007

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells gan Dharminder Chauhan, Madhavi Bandi, Ajita Singh, Arghya Ray, Noopur Raje, Paul G. Richardson, Kenneth C. Anderson

Cyhoeddwyd 2011

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib gan Arghya Ray, Zhouyang Tian, Deepika Sharma Das, Robert L. Coffman, Paul Richardson, Dharminder Chauhan, KS Anderson

Cyhoeddwyd 2014

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL gan Ellen Weisberg, Paul W. Manley, J. Mestan, Sandra W. Cowan‐Jacob, Arghya Ray, James D. Griffin

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD®immunomodulatory drug pomalidomide gan Deepika Sharma Das, Arghya Ray, Yan Song, Paul G. Richardson, Mohit Trikha, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2015

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells gan Arghya Ray, Deepika Sharma Das, Yan Song, Paul G. Richardson, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2015

Cael y testun llawn
Carta

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms gan Aditi Deshpande, Mamatha M. Reddy, Georg O.M. Schade, Arghya Ray, Tirumala Kumar Chowdary, J D Griffin, Martin Sattler

Cyhoeddwyd 2011

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma gan Yan Song, Arghya Ray, S Li, Deepika Sharma Das, Yu‐Tzu Tai, Ruben D. Carrasco, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2016

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells gan Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2017

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells gan Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia E. Paba‐Prada, Nikhil Munshi, Paul Richardson, Rolf Lewensohn, Kenneth C. Anderson

Cyhoeddwyd 2013

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

A novel alkylating agent Melflufen induces irreversible <scp>DNA</scp> damage and cytotoxicity in multiple myeloma cells gan Arghya Ray, Durgadevi Ravillah, Deepika Sharma Das, Yan Song, Eva Nordström, Joachim Gullbo, Paul G. Richardson, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2016

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells gan Deepika Sharma Das, Arghya Ray, Abhishek Das, Yan Song, Zhouyang Tian, Bryan Oronsky, Paul G. Richardson, Jan Scicinski, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2016

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance gan Ze Tian, Pádraig D’Arcy, Xin Wang, Arghya Ray, Yu‐Tzu Tai, Yiguo Hu, Ruben D. Carrasco, Paul G. Richardson, Stig Linder, Dharminder Chauhan, Kenneth C. Anderson

Cyhoeddwyd 2013

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma gan Yan Song, Paul M.C. Park, Lei Wu, Arghya Ray, S. Picaud, Deyao Li, Virangika K. Wimalasena, Ting Du, P. Filippakopoulos, Kenneth C. Anderson, Jun Qi, Dharminder Chauhan

Cyhoeddwyd 2019

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells gan Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett, Sophia Adamia, Richard M. Stone, Ilene Galinsky, Andrew L. Kung, James D. Griffin

Cyhoeddwyd 2008

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib Sensitivity gan Ellen Weisberg, Renee D. Wright, Jingrui Jiang, Arghya Ray, Daisy Moreno, Paul W. Manley, Doriano Fabbro, Elizabeth Hall–Meyers, Laurie Catley, Klaus Podar, Andrew L. Kung, James D. Griffin

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

Smac mimetics: implications for enhancement of targeted therapies in leukemia gan Ellen Weisberg, Arghya Ray, Rosemary Barrett, Erik A. Nelson, Amanda L. Christie, Dale Porter, Christopher Straub, Leigh Zawel, John Daley, Suzan Lazo-Kallanian, Richard Stone, Ilene Galinsky, David A. Frank, Andrew L. Kung, James D. Griffin

Cyhoeddwyd 2010

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells gan Ellen Weisberg, Lolita Banerji, Renee D. Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno, Laurence Catley, Jingrui Jiang, Elizabeth Hall–Meyers, Sauveur-Michel Maira, Richard M. Stone, Ilene Galinsky, Edward Fox, Andrew L. Kung, James D. Griffin

Cyhoeddwyd 2008

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future gan Arghya Ray, Bengt Nordén

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma gan Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C. Anderson

Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study gan Arghya Ray, Sandra W. Cowan‐Jacob, Paul W. Manley, Jürgen Mestan, James D. Griffin

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells gan Dharminder Chauhan, Madhavi Bandi, Ajita Singh, Arghya Ray, Noopur Raje, Paul G. Richardson, Kenneth C. Anderson

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib gan Arghya Ray, Zhouyang Tian, Deepika Sharma Das, Robert L. Coffman, Paul Richardson, Dharminder Chauhan, KS Anderson

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL gan Ellen Weisberg, Paul W. Manley, J. Mestan, Sandra W. Cowan‐Jacob, Arghya Ray, James D. Griffin

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD<sup>®</sup>immunomodulatory drug pomalidomide gan Deepika Sharma Das, Arghya Ray, Yan Song, Paul G. Richardson, Mohit Trikha, Dharminder Chauhan, Kenneth C. Anderson

Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells gan Arghya Ray, Deepika Sharma Das, Yan Song, Paul G. Richardson, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms gan Aditi Deshpande, Mamatha M. Reddy, Georg O.M. Schade, Arghya Ray, Tirumala Kumar Chowdary, J D Griffin, Martin Sattler

Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma gan Yan Song, Arghya Ray, S Li, Deepika Sharma Das, Yu‐Tzu Tai, Ruben D. Carrasco, Dharminder Chauhan, Kenneth C. Anderson

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells gan Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

<i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells gan Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia E. Paba‐Prada, Nikhil Munshi, Paul Richardson, Rolf Lewensohn, Kenneth C. Anderson

A novel alkylating agent Melflufen induces irreversible <scp>DNA</scp> damage and cytotoxicity in multiple myeloma cells gan Arghya Ray, Durgadevi Ravillah, Deepika Sharma Das, Yan Song, Eva Nordström, Joachim Gullbo, Paul G. Richardson, Dharminder Chauhan, Kenneth C. Anderson

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells gan Deepika Sharma Das, Arghya Ray, Abhishek Das, Yan Song, Zhouyang Tian, Bryan Oronsky, Paul G. Richardson, Jan Scicinski, Dharminder Chauhan, Kenneth C. Anderson

Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma gan Yan Song, Paul M.C. Park, Lei Wu, Arghya Ray, S. Picaud, Deyao Li, Virangika K. Wimalasena, Ting Du, P. Filippakopoulos, Kenneth C. Anderson, Jun Qi, Dharminder Chauhan

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells gan Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett, Sophia Adamia, Richard M. Stone, Ilene Galinsky, Andrew L. Kung, James D. Griffin

Canlyniadau Chwilio - Arghya Ray

Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future gan Arghya Ray, Bengt Nordén

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma gan Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C. Anderson

Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study gan Arghya Ray, Sandra W. Cowan‐Jacob, Paul W. Manley, Jürgen Mestan, James D. Griffin

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells gan Dharminder Chauhan, Madhavi Bandi, Ajita Singh, Arghya Ray, Noopur Raje, Paul G. Richardson, Kenneth C. Anderson

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib gan Arghya Ray, Zhouyang Tian, Deepika Sharma Das, Robert L. Coffman, Paul Richardson, Dharminder Chauhan, KS Anderson

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL gan Ellen Weisberg, Paul W. Manley, J. Mestan, Sandra W. Cowan‐Jacob, Arghya Ray, James D. Griffin

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD<sup>®</sup>immunomodulatory drug pomalidomide gan Deepika Sharma Das, Arghya Ray, Yan Song, Paul G. Richardson, Mohit Trikha, Dharminder Chauhan, Kenneth C. Anderson

Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells gan Arghya Ray, Deepika Sharma Das, Yan Song, Paul G. Richardson, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms gan Aditi Deshpande, Mamatha M. Reddy, Georg O.M. Schade, Arghya Ray, Tirumala Kumar Chowdary, J D Griffin, Martin Sattler

Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma gan Yan Song, Arghya Ray, S Li, Deepika Sharma Das, Yu‐Tzu Tai, Ruben D. Carrasco, Dharminder Chauhan, Kenneth C. Anderson

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells gan Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson

<i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells gan Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia E. Paba‐Prada, Nikhil Munshi, Paul Richardson, Rolf Lewensohn, Kenneth C. Anderson

A novel alkylating agent Melflufen induces irreversible <scp>DNA</scp> damage and cytotoxicity in multiple myeloma cells gan Arghya Ray, Durgadevi Ravillah, Deepika Sharma Das, Yan Song, Eva Nordström, Joachim Gullbo, Paul G. Richardson, Dharminder Chauhan, Kenneth C. Anderson

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells gan Deepika Sharma Das, Arghya Ray, Abhishek Das, Yan Song, Zhouyang Tian, Bryan Oronsky, Paul G. Richardson, Jan Scicinski, Dharminder Chauhan, Kenneth C. Anderson

Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma gan Yan Song, Paul M.C. Park, Lei Wu, Arghya Ray, S. Picaud, Deyao Li, Virangika K. Wimalasena, Ting Du, P. Filippakopoulos, Kenneth C. Anderson, Jun Qi, Dharminder Chauhan

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells gan Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett, Sophia Adamia, Richard M. Stone, Ilene Galinsky, Andrew L. Kung, James D. Griffin

Offerynnau Chwilio:

Pynciau Perthynol